Showing results (131-140 of 241) with videos related to
Sort By:
Pageof 25
World Journal of Urology|July 27, 2025
Evaluation of citrate-based nutraceutical combinations and their impact on chemolysis in the management of urinary diversion device: a randomised double-blind placebo-controlled study on improved quality of life and clinical outcomesAnna Ricapito, Nicola Schiavone, Marco Finati, et al.Journal of Translational Medicine|April 12, 2016
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunctionMargherita Gigante, Paola Pontrelli, Wolfgang Herr, et al.Current Oncology (Toronto, Ont.)|February 24, 2022
Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic PitfallsMagda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.Urologic Oncology|March 30, 2020
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancerFrancesca Sanguedolce, Ugo Giovanni Falagario, Pietro Castellan, et al.The International Journal of Biological Markers|April 6, 2013
VHL gene alterations in Italian patients with isolated renal cell carcinomasLucia Anna Muscarella, Leonardo D'Agruma, Annamaria la Torre, et al.International Urology and Nephrology|February 22, 2023
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablationOscar Selvaggio, Marco Finati, Ugo Giovanni Falagario, et al.Minerva Urology and Nephrology|September 11, 2024
Overactive bladder: results from patients treated by hyaluronic acid-chondroitin sulphate therapyRoberto Falabella, Simone Morra, Luigi Milella, et al.Urologic Oncology|August 27, 2011
JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implicationsMichela de Martino, Maddalena Gigante, Luigi Cormio, et al.Minerva Urology and Nephrology|September 25, 2024
Prostate cancer diagnostic pathway in men with lower urinary tract symptoms or performing opportunistic screening: The Italian Society of Urology (SIU) position paperVincenzo Ficarra, Riccardo Bartoletti, Marco Borghesi, et al.International Journal of Molecular Sciences|February 11, 2023
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary BiopsiesUgo Giovanni Falagario, Gian Maria Busetto, Marco Recchia, et al.Pageof 25